Patents by Inventor Bruno Meloni

Bruno Meloni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEUROPROTECTIVE PEPTIDES
    Publication number: 20220111003
    Abstract: The invention relates to the use of an isolated peptide of 10 to 32 amino acid residues in length for the treatment of neural injury, wherein the isolated peptide comprises at least 10 to 22 arginine residues. The peptide may be a poly-arg sequence or an arginine-rich peptide.
    Type: Application
    Filed: December 20, 2021
    Publication date: April 14, 2022
    Inventor: Bruno Meloni
  • Neuroprotective peptides
    Patent number: 11229678
    Abstract: The invention relates to the use of an isolated peptide of 10 to 32 amino acid residues in length for the treatment of neural injury, wherein the isolated peptide comprises at least 10 to 22 arginine residues. The peptide may be a poly-arg sequence or an arginine-rich peptide.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: January 25, 2022
    Assignee: ARGENICA THERAPEUTICS PTY LTD
    Inventor: Bruno Meloni
  • Neuroprotective Peptides
    Publication number: 20180326001
    Abstract: The invention relates to the use of an isolated peptide of 10 to 32 amino acid residues in length for the treatment of neural injury, wherein the isolated peptide comprises at least 10 to 22 arginine residues. The peptide may be a poly-arg sequence or an arginine-rich peptide.
    Type: Application
    Filed: July 20, 2018
    Publication date: November 15, 2018
    Inventor: Bruno Meloni
  • NEUROPROTECTIVE PEPTIDES
    Publication number: 20160250285
    Abstract: The invention relates to the use of an isolated peptide of 10 to 32 amino acid residues in length for the treatment of neural injury, wherein the isolated peptide comprises at least 10 to 22 arginine residues. The peptide may be a poly-arg sequence or an arginine-rich peptide.
    Type: Application
    Filed: October 30, 2014
    Publication date: September 1, 2016
    Applicant: University of Western Australia
    Inventor: Bruno Meloni
  • Neuroactive agents and methods of their use
    Publication number: 20080145340
    Abstract: This invention is related to a method of controlling neurodegeneration by increasing CD 147 receptor signaling. Neuroprotection can be achieved suing cyclophilin A or a functional variant, analog or derivative as a ligand for the CDE 147 receptor administered in various means including gene therapy. Conditions treatable with this method include cerebra ischemia, Alzheimer's Disease, Parkinson's Disease, Motor Neurone Disease and/or N=neuronal loss due to trauma and spinal cord damage.
    Type: Application
    Filed: August 10, 2007
    Publication date: June 19, 2008
    Inventors: Bruno Meloni, Sherif Boulos, Neville W. Kunckey